Shire’s Xiidra Gets US FDA Approval
US Food and Drug Administration approved Xiidra, which is lifitegrast ophthalmic solution 5 %,used to treat dry eye disease. Xiidra
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine